This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Xuan Zhou, PhD
Senior Scientist, Oligonucleotide Development at Biogen

Profile

Senior Scientist, Biogen 2022.3 - Present 

Antisense oligonucleotide process research and development Scientist II, Biogen 2019.08 - 2022.3 

Scientist I, Biogen 2016.10 - 2019.08 

Post-Doctoral Research in Organic Chemistry- University of Texas at Austin 2012-2016 

Ph.D. in Medicinal Chemistry - Sichuan University, China-2012

Agenda Sessions

  • Development of Kilogram-Scale Convergent Liquid-Phase Synthesis of Oligonucleotides

    08:45